So sánh phương pháp

	Trail Making Test	Bài kiểm tra nhận thức Addenbrooke (ACE)
Lĩnh vực	Tâm lý học thần kinh	Tâm lý học thần kinh
Họ	Process / pipeline	Process / pipeline
Năm ra đời	1958	2000
Người khởi xướng	Ralph Reitan	Padasalai Mathuranath
Loại	Clinician-administered neuropsychological test of attention and executive function	Clinician-administered comprehensive cognitive examination
Công trình gốc	Reitan, R. M. (1958). Validity of the Trail Making Test as an indicator of organic brain damage. Perceptual and Motor Skills, 8(3), 271-276.	Mathuranath, P. S., Nestor, P. J., Berrios, G. E., Rakowicz, W., & Hodges, J. R. (2000). A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia. Neurology, 55(11), 1613-1620.
Tên gọi khác	TMT, Trails A, Trails B, Trail Making A	ACE, ACE-R, ACE-III, Addenbrooke Cognitive Examination
Liên quan	5	5
Tóm tắt	The Trail Making Test (TMT) is a simple, brief neuropsychological test developed by Reitan in 1958 that measures visuomotor processing speed, attention, and executive function. The TMT comprises two forms: Part A, which assesses basic processing speed and visual scanning, and Part B, which assesses executive function, task-switching, and cognitive flexibility. Despite its simplicity, the TMT is highly sensitive to cognitive impairment across a wide range of neurological and psychiatric conditions and remains one of the most widely used screening tests in neuropsychology.	The Addenbrooke's Cognitive Examination (ACE) is a brief yet comprehensive clinician-administered cognitive battery designed to assess multiple cognitive domains and differentiate between types of dementia. Originally developed by Mathuranath and colleagues at Cambridge University in 2000, the ACE was created to address limitations of single-domain screening tools. The revised version (ACE-R, 2006) and further refined version (ACE-III, 2013) provide updated norms and improved sensitivity. The ACE-R and ACE-III are particularly valuable for distinguishing Alzheimer's disease from frontotemporal dementia.